Memorial Sloan Kettering Cancer Center-David H. Koch Center

New York, New York 10021

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Diffuse Large B-Cell Lymphoma, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes

Studies at this site

• A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes — Recruiting now
• A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma — Stopped early